Edelson Lechtzin LLP Launches Investigation of Semler Scientific, Inc. Over Securities Violations

Investigation Alert: Semler Scientific, Inc. Under Scrutiny

Edelson Lechtzin LLP, a prominent national class action law firm, has begun investigating Semler Scientific, Inc. (NASDAQ: SMLR) for potential breaches of federal securities laws. This investigation arises from recent allegations that the company may have provided misleading information to its investors, which could have had significant consequences on their financial well-being.

Background of Semler Scientific

Semler Scientific, based in the healthcare technology sector, primarily focuses on developing and marketing products aimed at enhancing the early detection and management of chronic diseases. Their flagship product, QuantaFlo, is a vascular testing device that plays a crucial role in the monitoring of cardiovascular health. Despite its important contributions to healthcare, Semler's recent disclosures have raised red flags.

Allegations and Market Impact

The catalyst for this investigation occurred on February 28, 2025, when Semler filed its annual report with the Securities and Exchange Commission (SEC). In this report, the company revealed that the Department of Justice is contemplating a False Claims Act complaint related to insurance reimbursement claims tied to the QuantaFlo device. This disclosure sent shockwaves through the market; in the subsequent trading session on March 3, 2025, Semler's stock plummeted by $4.03 per share, a staggering decline of 9.4%, resulting in a closing price of $38.89.

This sharp decline in stock value has raised concerns among investors, prompting Edelson Lechtzin LLP to encourage those who have experienced substantial losses to come forward. They are particularly interested in any non-public information that could aid in the investigation.

Moving Forward: How to Participate

For investors who believe they have been negatively affected by Semler’s actions or anyone with relevant information, the law firm invites you to contact them. You can reach attorney Eric Lechtzin by calling 844-563-5550 or by emailing [email protected] This could be an opportunity for affected individuals to regain control following significant losses.

The Role of Edelson Lechtzin LLP

Edelson Lechtzin LLP has built a reputation as a diligent class action law firm, not only focusing on investment and securities fraud but actively pursuing cases involving antitrust violations, wage theft, and data security breaches. Their expertise is essential in navigating the complexities of federal securities laws, especially in situations like the one involving Semler Scientific.

For additional inquiries related to this investigation, potential claimants can reach out to the firm directly at their Newtown, Pennsylvania office or through their legal contacts provided in the press release.

As these developments unfold, those monitoring Semler Scientific and the healthcare technology market will undoubtedly remain vigilant, as this investigation could have far-reaching implications for the company and its investors. Stay tuned for further updates as new information emerges regarding this significant legal scrutiny.